Coronary Artery Disease
Coronary artery bypass surgery may lead to metabolic changes, causing new-onset diabetes.
Patients with coronary artery disease who were previously not considered candidates for CABG may benefit from the surgery.
Sitting for prolonged periods of time is linked to worse health in patients with coronary artery disease.
The 2013 ACC/AHA cholesterol management guidelines better identify the risk of CVD and presence of coronary artery disease.
Testing patients with acute chest pain and low clinical risks had a low yield for coronary artery disease.
There is a relative 13.5% increase in coronary artery disease risk for every 2.5 inches shaved off a person's height.
Intensive lifestyle modifications were associated with a decrease in atherosclerotic burden in both coronary and carotid vasculature systems.
Patients with non-obstructive coronary artery disease were about 2 to 4.5 times more likely to have suffered an MI or died with no apparent CAD.
Hypertension is the leading modifiable risk factor for coronary artery disease, stroke, heart failure, and chronic kidney disease.
Low alcohol intake, healthy diet, low and physical activity decreased coronary artery calcification after 20 years.
Risk of adverse cardiovascular events is approximately doubled in patients with coronary artery disease.
A new study suggests that a transitional care program involving cardiac surgery NPs reduces readmission for discharged coronary artery bypass graft patients.
Difficulty falling asleep, difficulty staying asleep and sleeping too much may pose significant risk factors for obesity, myocardial infarction, stroke, coronary artery disease and diabetes.
Statins are widely used for treating elevated cholesterol for both primary and secondary prevention of coronary artery disease. One concern about their use has been the possibility of increasing the risk of diabetes.
Nonsteroidal anti-inflammatory drugs have been linked with increased risk for atrial fibrillation and adverse events in patients with hypertension and coronary artery disease.
Patient reported functional capacity does not accurately reflect exercise determined capacity, data presented during a poster presentation at the American Academy of Physician Assistants' 39th Annual Meeting indicates.
Investigators find that triglyceride levels are an independent risk factor for heart disease.
Does a single Framingham Risk score >20% permanently establish the LDL goal at 100?
Considered an unlikely candidate for CAD, her chest pains were misdiagnosed as tracheitis.
According to new studies, the answer is yes. But how good is the evidence, and what should the target be for which patients?
Combing through the best and latest trials, our experts synthesize the findings. Learn which patients need drugs and which drugs are best.
The patient's ECG was first interpreted as normal, but he later suffered an MI following surgery.
Dietary adherence is associated with reduced progression of coronary artery atherosclerosis in women with established CAD.
Patients with kidney impairment seem to require lower doses of warfarin and may need closer monitoring to avoid serious bleeding complications.
The FDA has approved Trilipix (fenofibric acid), a delayed-release capsule for use along with diet to treat dyslipidemia. Trilipix is the first fibrate to be approved for use in combination with a statin.
Blood sugar goals, stem cells, CT scans, health reform--these are some of the issues to make the list of most important stories of the year, as chosen by the Harvard Health Letter.
Statin use does not decrease renal-function loss in patients without cardiovascular disease (CVD) or in those at risk for it, but the drug is effective for primary prevention of CVD, a study found.